1. Combination of cytoplasmic and nuclear girdin expression is an independent prognosis factor of breast cancer
   Huikun Zhang et al, 2018, The FASEB Journal CrossRef
2. GIV/Girdin (Gα-interacting, Vesicle-associated Protein/Girdin) Creates a Positive Feedback Loop That Potentiates Outside-in Integrin Signaling in Cancer Cells
   Anthony Leyme et al, 2016, Journal of Biological Chemistry CrossRef
3. Girdin protein: A potential metastasis predictor associated with prognosis in lung cancer
   Zhaoyang Yang et al, 2018, Experimental and Therapeutic Medicine CrossRef
4. Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers
   Ying Dunkel et al, 2016, The FASEB Journal CrossRef
5. Integrins activate trimeric G proteins via the nonreceptor protein GIV/Girdin
   Anthony Leyme et al, 2015, Journal of Cell Biology CrossRef
6. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon Cancer
   Pradipta Ghosh et al, 2016, Clinical Cancer Research CrossRef
7. Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra
   Pradipta Ghosh, 2015, Aging CrossRef
8. Long noncoding RNA MEG3 prevents vascular endothelial cell senescence by impairing miR-128-dependent Girdin downregulation
   Yong Lan et al, 2019, American Journal of Physiology-Cell Physiology CrossRef